Hoyoung Huh - 28 Apr 2023 Form 4 Insider Report for Peak Bio, Inc.

Role
Director
Signature
/s/ Dr. Hoyoung Huh
Issuer symbol
N/A
Transactions as of
28 Apr 2023
Net transactions value
+$1,130,775
Form type
4
Filing time
02 May 2023, 16:30:18 UTC
Previous filing
03 Nov 2022
Next filing
08 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PKBO Warrant (Right to Purchase) Award +1,884,625 1,884,625 28 Apr 2023 Common Stock 1,884,625 $0.6000 Direct F1
transaction PKBO Convertible Notes Award $1,130,775 $1,130,775 28 Apr 2023 Common Stock Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The warrants and convertible promissory notes (the "Convertible Notes") were received in consideration for the conversion of outstanding loans by Dr. Huh to the Issuer.
F2 The Convertible Notes accrue interest at 6.0% per annum. At any time prior to maturity, the Reporting Person may convert the unpaid principal amount of the Convertible Notes, together with any accrued but unpaid interest, into shares of the Company's common stock at a price per share equal to $0.60. The Convertible Notes mature on October 28, 2023.